FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma | 079937015 | Fentanyl Citrate | 2 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Ssm Hlth St Clare Hosp-Fnton | 016257528 | 60652-4272 | 60652-4272-1 | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Ssm Hlth St Clare Hosp-Fnton | 016257528 | 60652-0600 | 60652-0600-1 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Ssm Hlth St Clare Hosp-Fnton | 016257528 | 60652-6795 | 60652-6795-1 | Morphine Sulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Ssm Hlth St Clare Hosp-Fnton | 016257528 | 60652-0329 | 60652-0329-1 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Ssm Hlth St Clare Hosp-Fnton | 016257528 | 60652-0334 | 60652-0334-1 | Norepinephrine Bitartrate | .032 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Ssm Hlth St Clare Hosp-Fnton | 016257528 | 60652-0903 | 60652-0903-1 | Oxytocin | .06 U/1 mL | 2019-1 | valid | 2026-11-14 | |
| Ssm Hlth St Clare Hosp-Fnton | 016257528 | 60652-0104 | 60652-0104-1 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Ssm Hlth St Clare Hosp-Fnton | 016257528 | 60652-7536 | 60652-7536-1 | Succinylcholine Chloride | 20 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| Ssm Hlth St Clare Hosp-Fnton | 016257528 | 60652-9010 | 60652-9010-1 | Fentanyl Citrate | .01 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| SterRx | 049167014 | 70324-926 | 70324-926-01 | Norepinephrine | 16 mg/250 mL | 2019-1 | valid | 2026-11-14 | |
| SterRx | 049167014 | 70324-651 | 70324-651-01 | Norepinephrine | 4 mg/250 mL | 2019-1 | valid | 2026-11-14 | |
| SterRx | 049167014 | 70324-676 | 70324-676-01 | Norepinephrine | 8 mg/250 mL | 2019-1 | valid | 2026-11-14 | |
| SterRx | 049167014 | 70324-701 | 70324-701-01 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2019-1 | valid | 2026-11-14 | |
| SterRx | 049167014 | 70324-901 | 70324-901-01 | Phenylephrine Hydrochloride | 50 mg/250 mL | 2019-1 | valid | 2026-11-14 | |
| SterRx | 049167014 | 70324-326 | 70324-326-03 | Sodium Bicarbonate | 1.26 g/100 mL | 2019-1 | valid | 2026-11-14 | |
| SterRx | 049167014 | 70324-301 | 70324-301-07 | Sodium Bicarbonate | 4.2 g/50 mL | 2019-1 | valid | 2026-11-14 | |
| SterRx | 049167014 | 70324-326 | 70324-326-01 | Sodium Bicarbonate | 1.26 g/100 mL | 2019-1 | valid | 2026-11-14 | |
| Stokes Healthcare | 802110531 | Flurbiprofen | .4 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Hydromorphone | 2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Idoxuridine | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Methadone Hydrochloride | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Pilocarpine Hydrochloride | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .3 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .3 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .3 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | .3 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Buprenorphine | .5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Tacrolimus | 3 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Buprenorphine | .5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 20 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 20 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 20 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Cyclosporine | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| Stokes Healthcare | 802110531 | Diazepam | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| US Specialty Formulations LLC | 079181064 | 69389-044 | 69389-044-26 | Medroxyprogesterone Acetate | 150 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| US Specialty Formulations LLC | 079181064 | 69389-145 | 69389-145-22 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2.5 mg/1 mL; 4 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| US Specialty Formulations LLC | 079181064 | 69389-055 | 69389-055-23 | Pyridoxine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Chromic Chloride; Thiamine Hydrochloride; Methylcobalamin; Niacinamide Hydrochloride | 20 mg/1 mL; .5 mg/1 mL; 50 ug/1 mL; 20 mg/1 mL; .5 mg/1 mL; 20 mg/1 mL | 2019-1 | valid | 2026-11-14 | |
| US Specialty Formulations LLC | 079181064 | 69389-064 | 69389-064-22 | Sarracenia Purpurea | 5 mg/1 mL | 2019-1 | valid | 2026-11-14 |